Innate Immunity in Allergic Asthma

Recruiting now

Conditions studied: Asthma

In brief

The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.

Key facts

Study ID

NCT06068335

Run by

University of Central Florida

People needed

100

Starts

2021-10-18

Expected to finish

2025-06-01

Last updated by the study team

2024-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must be at least 18 years of age
• no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.

You may not qualify if…

• Pregnant women and prisoners will be excluded from the study.
• Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.

Where it is running

• University of Central Florida — Orlando, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.